ArticleCurrent medical science2023

Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony-stimulating Factor Therapy for Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Retrospective Study from a Single-Center.

Fan-Cong Kong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.